Fig. 1From: The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosisDesign of animal experiments (1–5). The liraglutide dose was 17 nmol/kg/day, unless otherwise specified. N-omega-nitro-l-arginine methyl ester (l-NAME) was administered via drinking water at the dose of 20 mg/kg/day; LFA, left femoral arteryBack to article page